Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.
Press releases published on June 25, 2025
Backslash Security Exposes Critical Flaws in Hundreds of Public MCP Servers
GlobeNewswire
·
June 25, 2025
TEL AVIV, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Backslash Security, the modern application security platform for the AI era, today published the findings from an analysis of thousands of public Model Context Protocol (MCP) servers, revealing that …
Rio Silver Announces Results of Annual General Meeting, Amends Purchase Agreement for Maria Norte
GlobeNewswire
·
June 25, 2025
VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO) (OTC: RYOOF), announces shareholder approval for all matters at the AGM. All resolutions presented at Rio Silver’s annual general …
Globex Receives Cash Payments
GlobeNewswire
·
June 25, 2025
ROUYN-NORANDA, Quebec, June 25, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …
Globex reçoit des paiements comptants
GlobeNewswire
·
June 25, 2025
ROUYN-NORANDA, Québec, 25 juin 2025 (GLOBE NEWSWIRE) -- ENTREPRISES MINIÈRES GLOBEX INC. (GMX – Bourse de Toronto, G1MN – Bourses de Francfort, Stuttgart, Berlin, Munich, Tradegate, Lang …
HashFly Introduces the Most Trusted No-Hardware Cloud Mining with High Daily Crypto Earnings
GlobeNewswire
·
June 25, 2025
London, UK, June 25, 2025 (GLOBE NEWSWIRE) -- As the demand for passive crypto income continues to rise in 2025, HashFly has taken a bold step forward by launching its most trusted cloud mining solution yet — requiring no hardware and offering users …
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
GlobeNewswire
·
June 25, 2025
Technology Co-Developed by the U.S. Department of Veterans Affairs and Emory University NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel …
Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
GlobeNewswire
·
June 25, 2025
June 25, 2025 Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company …
Latin Metals Amends Agreement for 100% Ownership of Drill-Ready Cerro Bayo Silver-Gold Project, Santa Cruz Province, Argentina
GlobeNewswire
·
June 25, 2025
VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Latin Metals Inc. ("Latin Metals" or the "Company") - (TSXV: LMS) (OTCQB: LMSQF) is pleased to announce that it has entered into an amending agreement (the "Amended Agreement") to complete …
ALPHAMIN ANNOUNCES APPOINTMENT OF DIRECTOR
GlobeNewswire
·
June 25, 2025
GRAND BAIE, MAURITIUS, June 25, 2025 (GLOBE NEWSWIRE) -- Alphamin Resources Corp. (AFM:TSXV, APH:JSE AltX) (the “Company” or “Alphamin”) announced today that, subject to regulatory approval, Mr. John Robertson, a Mauritian resident, has been appointed as a …
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
GlobeNewswire
·
June 25, 2025
Amneal holds exclusive U.S. commercialization rights; BLA filing expected in Q4 2025 Poised to be among the first wave of biosimilars in the $3.9 billion U.S. omalizumab market and an important growth driver for Amneal BRIDGEWATER, N.J., June 25, 2025 ( …
Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025
GlobeNewswire
·
June 25, 2025
BOSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that three …
ORYZON to Host Virtual KOL Event on July 9, 2025
GlobeNewswire
·
June 25, 2025
MADRID and CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that it will host a virtual KOL event on …
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
GlobeNewswire
·
June 25, 2025
SOUTH SAN FRANCISCO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the IND application submitted by its partner in China, Angel Pharmaceuticals Ltd. ( …
Century Announces Filing of March 31, 2025 Year End Financial Results, Management Discussion and Analysis and Annual Information Form
GlobeNewswire
·
June 25, 2025
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, June 25, 2025 (GLOBE NEWSWIRE) -- Century Global Commodities Corporation (“Century” or the “Company”) (TSX: CNT) is pleased to announce that it has filed its …
DIMERx Awarded Up to $15M by NIDA Under NIH HEAL Initiative® to Advance DMX-101 as a Non-Addictive Oral Therapy for Chronic Pain
GlobeNewswire
·
June 25, 2025
SAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc., a late-stage biopharmaceutical company entering growth phase, today announced it has been awarded a UG3/UH3 cooperative agreement (UG3DA061645) for up to $15 million from the National Institute …
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
GlobeNewswire
·
June 25, 2025
MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that new pharmacologic and pharmacokinetic in vivo data for investigational oral OPK-88006 tablet treatment …
Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
GlobeNewswire
·
June 25, 2025
CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the world afflicted with Alcohol Use Disorder Vancouver, Canada, June 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: …
Verano Unveils Bodega-Style Dispensary Experience at Zen Leaf Cave Creek in Phoenix
GlobeNewswire
·
June 25, 2025
Flipping the script on the traditional dispensary format, the new bodega-style shopping experience offers customers the freedom to browse and select their favorite items directly from shelves featuring one of the largest assortments of directly accessible …
Oncotelic Therapeutics Announces Publication of Landmark Study on TGFB2 Gene Methylation as a Positive Prognostic Marker in Pancreatic Cancer
GlobeNewswire
·
June 25, 2025
AGOURA HILLS, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) ("Oncotelic" or the "Company"), a clinical-stage biopharmaceutical company focused on RNA-based therapeutics, today announced the publication of a peer- …
MetasTx Secures NCI Grant to Enable the Advancement of Dual-Track Strategy Against Metastatic Prostate Cancer
GlobeNewswire
·
June 25, 2025
PITTSBURGH, June 25, 2025 (GLOBE NEWSWIRE) -- MetasTx, LLC, a biotechnology company focused on preventing the metastasis of solid tumor cancers – like prostate, breast and skin, announced today it has received a Small Business Innovation Research (SBIR) …